During the past decade, Mount Medical Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Medical Centre" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "CytRx" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Medical Centre" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Lymphoma Trials Office" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Mount Medical Centre" are "Breast Cancer" (3 trials), "Adenocarcinoma" (1 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Mount Medical Centre" in a lesser frequency.

Most popular intervention types in "Mount Medical Centre" are "Drug" (12 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "BIBW 2992" (2 trials), "Docetaxel" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials) and "Bosentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Medical Centre" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Mount Medical Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Mount Medical Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Medical Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".